series-c-plus
Stage
2
Investors
About
Vaxxas develops needle-free vaccine delivery technology designed to administer vaccines without traditional needles, aiming to improve immunisation efficiency and accessibility.
Explore Vaxxas's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.